Thyrotropin Alfa Patent Expiration

Thyrotropin Alfa is Used for diagnostic purposes in serum thyroglobulin (TG) testing. It was first introduced by Genzyme Corp in its drug Thyrogen on Nov 30, 1998.


Thyrotropin Alfa Patents

Given below is the list of patents protecting Thyrotropin Alfa, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Thyrogen US5840566 Isolation of a gene encoding human thyrotropin beta subunit Nov 24, 2015

(Expired)

Genzyme
Thyrogen US6365127 Isolation of a gene encoding human thyrotropin beta subunit Nov 24, 2015

(Expired)

Genzyme



Thyrotropin Alfa's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List